ArticleInflammopharmacology2026
Anti-inflammatory evaluation of HPLC-GC quantified phytochemicals from Acalypha indica L. using LPS-induced inflammation model.
Article in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundInflammation is a crucial host defense mechanism; however, its prolonged activation contributes to the pathogenesis of respiratory infections. Acalypha indica L. (Haritamanjari), widely used in South Asia, has limited data available on its quantitative phytochemical profile.
objectiveThis study aimed to quantify the identified compounds phytol, gallic acid, stigmasterol, and β-sitosterol of A. indica. Additionally, the in vivo anti-inflammatory potential of the crude extract, the n-hexane soluble fraction, and two selected phytochemicals (gallic acid and stigmasterol) was evaluated. METHODOLOGY: HPLC and GC analyses were performed to quantify four phytoconstituents in A. indica. The anti-inflammatory activity was evaluated using the LPS-induced rat model of inflammation. Serum cytokine levels such as IL-6 and TNF-α were also quantified using ELISA kits, and histopathological analyses of liver and lung tissues were performed.
resultsQuantitative analysis revealed stigmasterol (11.74 mg/g, 1.17%), β-sitosterol (10.88 mg/g, 1.08%), and gallic acid (12.58 mg/g (1.25%)) as major sterols and phenolic acids. Similarly, phytol was found to be 8.76 mg/g (0.87%) in the plant A. indica. The treatments of gallic acid (150 mg/kg b.wt.) and stigmasterol (100 mg/kg b.wt.) significantly reduced IL-6 and TNF-α levels (p < 0.001) and restored tissue integrity, reducing inflammatory infiltration, vascular congestion, and edema.
conclusionA. indica and its bioactive constituents, particularly gallic acid and stigmasterol, exert significant anti-inflammatory effects. Thus, the n-hexane fraction emerges as a potential reservoir of naturally derived compounds with significant anti-inflammatory activity.
Indexed as
Identifiers
42498902What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.